|
|
| | L-Cysteine, S-[3-[[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]amino]-3-oxo-1-(1-piperidinylmethyl)propyl]- Basic information |
| | L-Cysteine, S-[3-[[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]amino]-3-oxo-1-(1-piperidinylmethyl)propyl]- Chemical Properties |
| Boiling point | 798.9±60.0 °C(Predicted) | | density | 1.412±0.06 g/cm3(Predicted) | | pka | 2.04±0.10(Predicted) |
| | L-Cysteine, S-[3-[[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]amino]-3-oxo-1-(1-piperidinylmethyl)propyl]- Usage And Synthesis |
| Uses | Dacomitinib metabolite M1/2 is a potent inhibitor of both wild-type (WT) EGFR and the T790M mutation, demonstrating significant activity against acquired resistance mechanisms in EGFR-mutant non-small-cell lung cancer (NSCLC). | | References | [1] Dacomitinib in lung cancer: a "lost generation" EGFR tyrosine-kinase inhibitor from a bygone era DOI:10.2147/DDDT.S52787 |
| | L-Cysteine, S-[3-[[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]amino]-3-oxo-1-(1-piperidinylmethyl)propyl]- Preparation Products And Raw materials |
|
|
Tag:L-Cysteine, S-[3-[[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]amino]-3-oxo-1-(1-piperidinylmethyl)propyl]-(1262034-38-7)
Related Product Information
|
|
EGFR Protein, HUMAN (621A.A, HEK293, FC)
EGFR protein, HUMAN (BIOTINYLATED, HEK293, HIS-AVI)
HER2/CD340 protein, HUMAN (BIOTINYLATED, HEK293, HIS)
HER3 Protein, HUMAN (BIOTINYLATED, HEK293, HIS-AVI)
Amivantamab
HER2/CD340 Protein, RAT (HEK293)
|